Download PDF

Other users also viewed these articles

Prognostic value of cerebrospinal fluid biomarkers in mild cognitive impairment due to Alzheimer disease R. López-Cuevas; M. Baquero-Toledo; A. Cuevas-Jiménez; N. Martín-Ibáñez; R. Pascual-Costa; M.J. Moreno-Monedero; A. Cañada-Martínez; C. Peña-Bautista; I. Ferrer-Cairols; L. Álvarez-Sánchez; C. Cháfer-Pericás;
Neurologia. 2023;38:262-9
Blood-based biomarkers for Alzheimer's disease: positioning document and usage recommendations from the Behavioral Neurology and Dementia Study Group of the Spanish Society of Neurology M. Suárez-Calvet; C. Abdelnour; D. Alcolea; M. Mendióroz-Iriarte; M. Balasa; E. Morenas-Rodríguez; A. Puig-Pijoan; P. Sánchez-Juan; A. Villarejo; R. Sánchez-Valle;
Neurologia. 2025;40:700-12
Spanish normative studies (NEURONORMA-Plus project): norms for the Wisconsin Card Sorting Test, the Modified Taylor Complex Figure, and the Ruff-Light Trail Learning Test C. Pérez-Enríquez; G. García-Escobar; M. Florido-Santiago; J. Piqué-Candini; C. Arrondo-Elizarán; L. Grau-Guinea; B. Pereira-Cuitiño; R.M. Manero; A. Puig-Pijoan; J. Peña-Casanova; G. Sánchez-Benavides;
Neurologia. 2024;39:235-43